| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $1.35B | +18.5% |
| Cost of Revenue | $1.04B | +22.4% |
| Gross Profit | $307.9M | +7.2% |
| R&D Expense | $40.0M | -0.7% |
| SG&A Expense | $240.2M | +12.2% |
| Operating Income | $25.6M | -11.7% |
| Interest Expense | $9.6M | -36.8% |
| Pre-tax Income | $34.0M | +28.3% |
| Income Tax | $12.0M |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $560.6M | +70.2% |
| Accounts Receivable | $165.0M | +40.4% |
| Current Assets | $1.26B | +44.8% |
| Total Assets | $2.47B | +26.5% |
| Current Liabilities | $311.0M | +4.8% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $470.9M | -21.2% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.1M | -184.7% |
| Investing Cash Flow | -$88.3M | -26.7% |
| Financing Cash Flow | $360.7M | +29.9% |
| +17.6% |
| Net Income | $22.0M | +35.0% |
| EPS (Basic) | $0.14 | +27.3% |
| EPS (Diluted) | $0.13 | +18.2% |
| Stockholders' Equity |
| $2.00B |
| +47.5% |